Trial Profile
A 12 week, open, randomized, parallel, multicenter study of efficacy, tolerability and safety of hydrochlorothiazide (+) losartan potassium versus amlodipine in essential hypertensive patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Losartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Organon
- 01 Feb 2007 Status changed from in progress.
- 05 Nov 2005 New trial record.